Ledger.Open graph →
SEC Form D · filed September 14, 2017

GT Biopharma, Inc

Offering
$4.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Washington, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Steven Weldon · Las Vegas, NVExec · DirectorAnthony Cataldo · Los Angeles, CAExec · DirectorSteven Weldon · Washington, Washington, D.C.Exec · DirectorKathleen Clarence-Smith · Washington, Washington, D.C.Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗